PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 36 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.53 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $156,000 | -9.8% | 214,938 | +3.8% | 0.00% | 0.0% |
| Q2 2017 | $173,000 | -60.9% | 207,100 | -36.4% | 0.00% | -71.4% |
| Q1 2017 | $442,000 | +22000.0% | 325,640 | +6412.8% | 0.01% | – |
| Q3 2016 | $2,000 | -77.8% | 5,000 | -66.7% | 0.00% | – |
| Q2 2016 | $9,000 | – | 15,000 | +29900.0% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 50 | -87.1% | 0.00% | – |
| Q4 2015 | $9,000 | -62.5% | 387 | -36.9% | 0.00% | -100.0% |
| Q3 2015 | $24,000 | +84.6% | 613 | -42.7% | 0.00% | – |
| Q2 2015 | $13,000 | -51.9% | 1,070 | +19.7% | 0.00% | -100.0% |
| Q1 2015 | $27,000 | +200.0% | 894 | +1092.0% | 0.00% | – |
| Q3 2014 | $9,000 | +800.0% | 75 | +837.5% | 0.00% | – |
| Q4 2013 | $1,000 | -97.4% | 8 | -98.3% | 0.00% | -100.0% |
| Q3 2013 | $39,000 | – | 479 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zhang Financial LLC | 45,000 | $36,000 | 0.02% |
| A.R.T. Advisors, LLC | 381,955 | $319,000 | 0.02% |
| Virtu KCG Holdings LLC | 705,907 | $591,000 | 0.02% |
| OXFORD ASSET MANAGEMENT LLP | 687,796 | $576,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 89,813 | $73,000 | 0.01% |
| FEDERATED HERMES, INC. | 1,945,682 | $1,630,000 | 0.01% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 324,479 | $272,000,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 302,588 | $253,000 | 0.00% |
| WEDBUSH SECURITIES INC | 23,000 | $19,000 | 0.00% |
| Renaissance Technologies | 2,300,800 | $1,927,000 | 0.00% |